EVERSANA — Furosemide Importer Profile
Pharmaceutical Importer · #16 buyer for Furosemide · $2.1M import value · 50 shipments · UNITED STATES · DGFT Verified
EVERSANA is the #16 importer of Furosemide from India with $2.1M in import value and 50 verified shipments. EVERSANA holds a 1.4% market share in Furosemide imports based in UNITED STATES. The company sources from 3 verified suppliers across 23 formulations shipped to 1 country. Overall, EVERSANA imports 12 pharmaceutical products worth $27.6M across 9 therapeutic categories.
EVERSANA — Furosemide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Furosemide to EVERSANA?
Verified from 50 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $1.5M | 34 | 71.6% |
| INTAS PHARMACEUTICALS LIMITED | $367.9K | 10 | 17.6% |
| MAIVA PHARMA PRIVATE LIMITED | $228.0K | 6 | 10.9% |
EVERSANA sources Furosemide from 3 verified Indian suppliers based on 50 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 71.6% of imports.
How Does EVERSANA Compare to Nearest Furosemide Importers?
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $1.2M | 24 | $50.0K |
| 10 | ATHENEX PHARMACEUTICAL DIVISION | UNITED STATES | $1.1M | 23 | $50.0K |
| 16 | EVERSANA ★ | UNITED STATES | $1.0M | 20 | $50.0K |
| 18 | MINT PHARMACEUTICALS INC | CANADA | $750.0K | 15 | $50.0K |
| 15 | STERIMAX INC | CANADA | $700.0K | 14 | $50.0K |
EVERSANA ranks #16 among 778 Furosemide importers from India. Average shipment value of $50.0K compared to the market average of $39.5K. The closest competitors by value are NORTHSTAR DISTRIBUTION CENTER and ATHENEX PHARMACEUTICAL DIVISION.
Where Does EVERSANA Import Furosemide To?
Destination countries from 50 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.1M | 50 | 100.0% |
EVERSANA imports Furosemide to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.1M.
What Furosemide Formulations Does EVERSANA Import?
| Formulation | Value | Shipments |
|---|---|---|
| FUROSEMIDE INJECTION USP40MG/4ML 10MG/ML4ML FILL IN 5ML VIAL | $300.0K | 6 |
| FUROSEMIDE INJECTION USP 40MG/4ML (10MG/ML) 4ML FILL IN 5ML VIAL | $250.0K | 5 |
| PHR DRUGS&MEDI FUROSEMIDE INJ USP10MG/ML | $188.0K | 4 |
| FUROSEMIDE INJECTION USP,100MG/10ML (10MG/ML)10ML FILL IN 10ML VIALNOS | $132.0K | 6 |
| FUROSEMIDE INJECTION USP,20MG/2ML(10MG/ML)2ML FILL IN 2ML VIALNOS | $116.8K | 3 |
| PHARMA DRUGS & MEDI FUROSEMIDE INJ USP10MG/ML 4ML 10V(AC-US AS PER INVOICE | $112.7K | 3 |
| FUROSEMIDE INJECTION USP 10MG/ML, 2ML FI | $100.0K | 2 |
| FUROSEMIDE INJECTION USP 10MG/ML, 10ML F | $100.0K | 2 |
| FUROSEMIDE INJECTIONUSP,20MG/2ML(10MG/ML | $100.0K | 2 |
| FUROSEMIDE INJECTIONUSP,40MG/4ML(10MG/ML | $100.0K | 2 |
EVERSANA imports 23 distinct Furosemide formulations from India. The top formulation is FUROSEMIDE INJECTION USP40MG/4ML 10MG/ML4ML FILL IN 5ML VIAL with 6 shipments worth $300.0K.
Regulatory Requirements: Importing Furosemide into United States
What EVERSANA and other importers must comply with to import Furosemide from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Furosemide
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Furosemide from India and How Much Does EVERSANA Import?
India exported $30.7M worth of Furosemide through 4,657 shipments from 333 suppliers to 150 countries, serving 778 buyers globally. EVERSANA imports $2.1M of this total, accounting for 1.4% of India's Furosemide exports with 50 shipments from UNITED STATES. This is verified from 50 customs shipment records covering 23 distinct formulations.
What Is the Average Order Value for EVERSANA's Furosemide Imports?
EVERSANA's average Furosemide order value is $41.9K per consignment, based on 50 shipments totaling $2.1M. EVERSANA is based in UNITED STATES and ranks #16 among all Furosemide importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Furosemide to EVERSANA?
EVERSANA sources Furosemide from 3 verified Indian suppliers: GLAND PHARMA LIMITED ($1.5M, 71.6%), INTAS PHARMACEUTICALS LIMITED ($367.9K, 17.6%), MAIVA PHARMA PRIVATE LIMITED ($228.0K, 10.9%). This is based on 50 customs records.
How Does EVERSANA Compare to Other Furosemide Importers?
EVERSANA ranks #16 among 778 Furosemide importers from India with a 1.4% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ($6.3M), RISING PHARMA HOLDINGS INC ($4.2M), RISING PHARMA HOLDINGS INC,., ($3.6M). EVERSANA processed 50 shipments from UNITED STATES.
About EVERSANA
EVERSANA imports 12 products worth $27.6M. Beyond Furosemide, top products include Heparin, Enoxaparin, Syringe, Vancomycin, Sodium. View the complete EVERSANA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Furosemide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Furosemide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EVERSANA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EVERSANA's capped import value divided by total capped export value for Furosemide across all Indian exporters.
- 5.Verified Records: This page is backed by 50 individual customs records matching EVERSANA importing Furosemide, covering 23 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 778+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Furosemide Import Data for EVERSANA
Access order-level details, pricing data, supplier connections, and competitive analysis for EVERSANA's Furosemide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EVERSANA
Full Company Profile →
12 products · $27.6M total trade · 9 categories
EVERSANA × Furosemide
Verified from customs records
Company Overview
Top Products by EVERSANA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EVERSANA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Furosemide. For current order-level data, contact TransData Nexus.